Search research articles
Contact Us
Filters
Showing results (431-440 of 458) with videos related to
Page
of 46
Sort By:
Journal of Neurosurgery
|
July 1, 1993
Results of surgical treatment for growth hormone-secreting pituitary adenomas
D H Davis, E R Laws, D M Ilstrup, et al.
Journal of Neuro-Oncology
|
December 1, 1996
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor
T L Cascino, M H Veeder, J C Buckner, et al.
Investigational New Drugs
|
August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas
P A Burch, A M Bernath, T L Cascino, et al.
Cancer
|
February 15, 1997
Pituitary carcinoma: a clinicopathologic study of 15 cases
P J Pernicone, B W Scheithauer, T J Sebo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
J S Smith, A Perry, T J Borell, et al.
Journal of Neuro-Oncology
|
January 1, 1995
Phase II study of amonafide in patients with recurrent glioma
R Levitt, J C Buckner, T L Cascino, et al.
Clinical Neuropathology
|
April 5, 2005
Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors
T A Gaffey, B W Scheithauer, R W Leech, et al.
Molecular and Chemical Neuropathology
|
February 1, 1994
Neutral glycolipid composition of primary human brain tumors
L P Singh, D K Pearl, T K Franklin, et al.
Mayo Clinic Proceedings
|
November 18, 1998
Prolactinomas in male and female patients: a comparative clinicopathologic study
R D Calle-Rodrigue, C Giannini, B W Scheithauer, et al.
Journal of Neurosurgery
|
March 1, 1995
Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma
J C Buckner, L D Brown, J W Kugler, et al.
Page
of 46
Search research articles
Search
Showing results (431-440 of 458) with videos related to
Sort By:
Page
of 46
Journal of Neurosurgery
|
July 1, 1993
Results of surgical treatment for growth hormone-secreting pituitary adenomas
D H Davis, E R Laws, D M Ilstrup, et al.
Journal of Neuro-Oncology
|
December 1, 1996
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor
T L Cascino, M H Veeder, J C Buckner, et al.
Investigational New Drugs
|
August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas
P A Burch, A M Bernath, T L Cascino, et al.
Cancer
|
February 15, 1997
Pituitary carcinoma: a clinicopathologic study of 15 cases
P J Pernicone, B W Scheithauer, T J Sebo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
J S Smith, A Perry, T J Borell, et al.
Journal of Neuro-Oncology
|
January 1, 1995
Phase II study of amonafide in patients with recurrent glioma
R Levitt, J C Buckner, T L Cascino, et al.
Clinical Neuropathology
|
April 5, 2005
Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors
T A Gaffey, B W Scheithauer, R W Leech, et al.
Molecular and Chemical Neuropathology
|
February 1, 1994
Neutral glycolipid composition of primary human brain tumors
L P Singh, D K Pearl, T K Franklin, et al.
Mayo Clinic Proceedings
|
November 18, 1998
Prolactinomas in male and female patients: a comparative clinicopathologic study
R D Calle-Rodrigue, C Giannini, B W Scheithauer, et al.
Journal of Neurosurgery
|
March 1, 1995
Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma
J C Buckner, L D Brown, J W Kugler, et al.
Page
of 46